Keywords: Novartis, Staff reduction, USA, Pharma filed force, Cancer drugs, ASH

Novartis US unit restructures, slashing 1,400 pharma field staff; to showcase oncology drugs at ASH meeting

Article | 01 December 2010

Print This

Swiss drug major Novartis’ (NOVN: VX) US subsidiary says that it is restructuring its general medicines field force in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in